Carbenoxolone

DB02329ExperimentalSmall molecule

Carbenoxolone is a drug used to symptomatically treat lip sores and mouth ulcers. An agent derived from licorice root.

Mechanism: Pharmacologically active on 11-beta-hydroxysteroid dehydrogenase 1 and 11beta-hydroxysteroid dehydrogenase
Curator reviewed
Formula / weight: C₃₄H₅₀O₇ · 570.7566 g/mol (avg)

Resolves to

Compound

Clinical / RWD

Structure

[H][C@@]1(CC[C@@]2(C)[C@@]([H])(CC[C@]3(C)[C@]2([H])C(=O)C=C2[C@]4([H])C[C@](C)(CC[C@]4(C)CC[C@@]32C)C(O)=O)C1(C)C)OC(=O)CCC(O)=O

Targets

What you can answer from here — as of September 13, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Drug interactionStructured to mechanism, not free text

1Structured indicationCondition, population, route and combination as fields, not prose

6ContraindicationsEach with its own population and attribute set

1Marketed productAcross 1 country and 1 labeller

3ATC codesIncluding every combination product, plus 8 drug categories

11+ReferencesStructured and connected to the statements they support

Which drugs share a target with Carbenoxolone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.